Home > Insider Trading > Filing (0001567619-19-015979)

Filing Details

Accession Number:: 0001567619-19-015979
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-07 18:31:12
Reporting Period:: 2019-08-05

Accepted Time:: 2019-08-07 18:31:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1740689	Michael Lane	C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092	Corporate Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-08-05	2,010	$62.00	5,982	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	638	$79.54	6,620	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	136	$79.54	6,756	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	3	$67.85	6,759	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	6,190	$67.85	12,949	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	4,438	$141.60	17,387	No	4	M	Direct
Common Stock	Acquisiton	2019-08-05	1,999	$178.26	19,386	No	4	M	Direct
Common Stock	Disposition	2019-08-05	12,067	$263.89	7,319	No	4	S	Direct
Common Stock	Disposition	2019-08-05	2,547	$264.25	4,772	No	4	S	Direct
Common Stock	Disposition	2019-08-05	3,347	$264.73	1,425	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right-to-buy)	Disposition	2019-08-05	2,010	$0.00	2,010	$62.00
Common Stock	Incentive Stock Option (right-to-buy)	Disposition	2019-08-05	638	$0.00	638	$79.54
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-08-05	136	$0.00	136	$79.54
Common Stock	Incentive Stock Option (right-to-buy)	Disposition	2019-08-05	3	$0.00	3	$67.85
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-08-05	6,190	$0.00	6,190	$67.85
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-08-05	4,438	$0.00	4,438	$141.60
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-08-05	1,999	$0.00	1,999	$178.26

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2024-02-13	No	4	M	Direct
748	2025-02-13	No	4	M	Direct
2,226	2025-02-13	No	4	M	Direct
2,069	2026-02-13	No	4	M	Direct
4,559	2026-02-13	No	4	M	Direct
5,948	2027-02-13	No	4	M	Direct
7,435	2028-02-13	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	592	Indirect	by spouse

Footnotes

Includes 20 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 28, 2019.
Represents the weighted average sales price of the shares sold ranging from a low of $263.60 to a high of $264.54 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Represents the weighted average sales price of the shares sold ranging from a low of $264.62 to a high of $265.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniaryinterest therein.
Grant of option to buy 1,005 shares of Issuer common stock that became exercisable on the fifth anniversary of the date of grant without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 693 shares of Issuer common stock that vest in five annual installments beginning February 14, 2016 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 1,181 shares of Issuer common stock that vest in five annual installments beginning February 14, 2016 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Grant of option to buy 2,072 shares of Issuer common stock that vests as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2019, respectively, and as to the remainder on February 14, 2021.
Grant of option to buy 10,749 shares of Issuer common stock that vest in five annual installments beginning February 14, 2017.
Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
Grant of option to buy 9,434 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
Not applicable.